Heron Therapeutics（納斯達克代碼：HRTX）報告季度每股收益爲$0.02，超出分析師一致預期的$(0.03)，上漲166.67%。相比去年同期的每股虧損$(0.07)，這一收益增長了128.57%。公司報告的季度銷售額爲$40.78M，超出分析師預期的$37.37M，增長了9.14%。相比去年同期的$34.23M，銷售額增長了19.13%。

以上內容來自Benzinga Earnings專欄，原文如下：

Heron Therapeutics (NASDAQ:HRTX) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.03) by 166.67 percent. This is a 128.57 percent increase over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $40.78 million which beat the analyst consensus estimate of $37.37 million by 9.14 percent. This is a 19.13 percent increase over sales of $34.23 million the same period last year.